Fluorescein angiographic lesion type frequency in neovascular Age-Related macular degeneration
- 29 February 2004
- journal article
- Published by Elsevier in Ophthalmology
- Vol. 111 (2) , 250-255
- https://doi.org/10.1016/j.ophtha.2003.05.030
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Prevalence and causes of visual impairment according to World Health Organization and United States criteria in an aged, urban Scandinavian population The Copenhagen City Eye StudyOphthalmology, 2001
- Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy report 2American Journal of Ophthalmology, 2001
- Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With VerteporfinArchives of Ophthalmology (1950), 1999
- Transpupillary thermotherapy of occult subfoveal choroidal neovascularization in patients with age-related macular degenerationOphthalmology, 1999
- Photodynamic Therapy With Verteporfin for Choroidal Neovascularization Caused by Age-related Macular DegenerationArchives of Ophthalmology (1950), 1999
- Photodynamic Therapy With Verteporfin for Choroidal Neovascularization Caused by Age-related Macular DegenerationArchives of Ophthalmology (1950), 1999
- Age-Specific Prevalence and Causes of Blindness and Visual Impairment in an Older PopulationArchives of Ophthalmology (1950), 1998
- Prevalence of Age-related Maculopathy in AustraliaOphthalmology, 1995
- SENILE MACULAR DEGENERATION: A CASE-CONTROL STUDYAmerican Journal of Epidemiology, 1983
- Cataracts and Macular Degeneration in Older AmericansArchives of Ophthalmology (1950), 1982